Vision Disturbances in Multiple Sclerosis

Seminars in Neurology

Volumn 36, Issue 2, 2016, Pages 185-195

  Costello, Fiona ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

diplopia; multiple sclerosis; nystagmus; optic neuritis; oscillopsia

Indexed keywords

FINGOLIMOD;

ARTICLE; BRAIN DISEASE; CLINICAL FEATURE; CONVALESCENCE; DORSAL MIDBRAIN SYNDROME; EYE MOVEMENT DISORDER; GAZE PARALYSIS; HUMAN; INFLAMMATION; INTERNUCLEAR OPHTHALMOPLEGIA; MACULAR EDEMA; MULTIPLE SCLEROSIS; NYSTAGMUS; OPHTHALMOPLEGIA; OPTIC NEURITIS; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SKEW DEVIATION; SMOOTH PURSUIT EYE MOVEMENT; UVEITIS; VERTICAL STRABISMUS; VESTIBULAR DISORDER; VESTIBULOOCULAR REFLEX; VISUAL DISORDER; COMPLICATION; QUALITY OF LIFE;

HUMANS; MULTIPLE SCLEROSIS; NYSTAGMUS, PATHOLOGIC; OPTIC NEURITIS; QUALITY OF LIFE; VISION DISORDERS;

EID: 84988373886     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0036-1579692     Document Type: Article

References (45)

1. Costello F. The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis. ISRN Neurol: 2013; 2013 134858
2. Balcer L. J., Miller D. H., Reingold S. C., Cohen J. A. Vision and vision-related outcome measures in multiple sclerosis. Brain: 2015; 138 Pt 1 11 27
3. Compston A., Coles A. Multiple sclerosis. Lancet: 2008; 372 9648 1502 1517
4. Costello F. E., Lee A. G., Burton J. M. Neuro-ophthalmic manifestations of multiple sclerosis. Available at: http://emedicine.medscape.com/article/1214270-overview. Accessed January 22, 2015
5. Miller D., Barkhof F., Montalban X., Thompson A., Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol: 2005; 4 5 281 288
6. Costello F., Burton J. M. An approach to optic neuritis: the initial presentation. Expert Rev Ophthalmol: 2013; 8 6 539 551
7. Beck R. W., Cleary P. A., Anderson M. M. Jr., et al. The Optic Neuritis Study Group. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med: 1992; 326 9 581 588
8. Beck R. W. Optic neuritis. In: Miller N. R., Newman N. J., eds. Walsh & Hoyt's Clinical Neuro-Ophthalmology. Vol, 5. 5th ed. Baltimore, MD Williams & Wilkins: 1999; 599 647
9. Wilejto M., Shroff M., Buncic J. R., Kennedy J., Goia C., Banwell B. The clinical features, MRI findings, and outcome of optic neuritis in children. Neurology: 2006; 67 2 258 262
10. Keltner J. L., Johnson C. A., Cello K. E., Dontchev M., Gal R. L., Beck R. W.; Optic Neuritis Study Group. Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years. Arch Ophthalmol: 2010; 128 3 330 337
11. Hickman S. J., Dalton C. M., Miller D. H., Plant G. T. Management of acute optic neuritis. Lancet: 2002; 360 9349 1953 1962
12. Costello F. Inflammatory optic neuropathies. Continuum (Minneap Minn): 2014; 20 (4 Neuro-ophthalmology): 816 837 (Minneap Minn)
13. Shams P. N., Plant G. T. Optic neuritis: a review. Int MS J: 2009; 16 3 82 89
14. Polman C. H., Reingold S. C., Banwell B., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol: 2011; 69 2 292 302
15. Modvig S., Degn M., Horwitz H., et al. Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis. PLoS ONE: 2013; 8 10 e77163
16. Heussinger N., Kontopantelis E., Gburek-Augustat J., et al. for GRACE-MS (German-speaking Research Alliance for ChildrEn with Multiple Sclerosis). Oligoclonal bands predict multiple sclerosis in children with optic neuritis. Ann Neurol: 2015; 77 6 1076 1082
17. Balcer L. J. Clinical practice. Optic neuritis. N Engl J Med: 2006; 354 12 1273 1280
18. van der Walt A., Kolbe S., Mitchell P., et al. Parallel changes in structural and functional measures of optic nerve myelination after optic neuritis. PLoS ONE: 2015; 10 5 e0121084
19. Sriram P., Wang C., Yiannikas C., et al. Relationship between optical coherence tomography and electrophysiology of the visual pathway in non-optic neuritis eyes of multiple sclerosis patients. PLoS ONE: 2014; 9 8 e102546
20. Syc S. B., Saidha S., Newsome S. D., et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain: 2012; 135 Pt 2 521 533
21. Costello F., Pan Y. I., Yeh E. A., Hodge W., Burton J. M., Kardon R. The temporal evolution of structural and functional measures after acute optic neuritis. J Neurol Neurosurg Psychiatry: 2015; 86 12 1369 1373
22. Gabilondo I., Martínez-Lapiscina E. H., Fraga-Pumar E., et al. Dynamics of retinal injury after acute optic neuritis. Ann Neurol: 2015; 77 3 517 528
23. Petzold A., de Boer J. F., Schippling S., et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol: 2010; 9 9 921 932
24. Fisher J. B., Jacobs D. A., Markowitz C. E., et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology: 2006; 113 2 324 332
25. Kupersmith M. J., Gal R. L., Beck R. W., Xing D., Miller N.; Optic Neuritis Study Group. Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome. Neurology: 2007; 69 6 508 514
26. Raz N., Dotan S., Benoliel T., Chokron S., Ben-Hur T., Levin N. Sustained motion perception deficit following optic neuritis: behavioral and cortical evidence. Neurology: 2011; 76 24 2103 2111
27. The Optic Neuritis Study Group Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol: 2008; 65 6 727 732
28. Martinelli V., Rocca M. A., Annovazzi P., et al. A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS. Neurology: 2009; 73 22 1842 1848
29. Burton J. M., O'Connor P. W., Hohol M., Beyene J. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Cochrane Database Syst Rev: 2009; 8 3 CD006921
30. Raz N., Chokron S., Ben-Hur T., Levin N. Temporal reorganization to overcome monocular demyelination. Neurology: 2013; 81 8 702 709
31. Pineles S. L., Birch E. E., Talman L. S., et al. One eye or two: a comparison of binocular and monocular low-contrast acuity testing in multiple sclerosis. Am J Ophthalmol: 2011; 152 1 133 140
32. Saidha S., Sotirchos E. S., Ibrahim M. A., et al. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol: 2012; 11 11 963 972
33. Gelfand J. M., Nolan R., Schwartz D. M., Graves J., Green A. J. Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain: 2012; 135 Pt 6 1786 1793
34. Saidha S., Syc S. B., Ibrahim M. A., et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain: 2011; 134 Pt 2 518 533
35. Kaya D., Kaya M., ÖzakbaŚ S., İdiman E. Uveitis associated with multiple sclerosis: complications and visual prognosis. Int J Ophthalmol: 2014; 7 6 1010 1013
36. Gordon L. K., Goldstein D. A. Gender and uveitis in patients with multiple sclerosis. J Ophthalmol: 2014; 2014 565262
37. McClelland C., Galetta S. Eye symptoms, signs, and therapy in multiple sclerosis. In: Rae-Grant A., Fox R., Bethoux F., eds. Multiple Sclerosis and Related Disorders: Diagnosis, Medical Management, and Rehabilitation. New York Demos Medical Publishing: 2013; 179 86
38. Walsh R. D., McClelland C. M., Galetta S. L. The neuro-ophthalmology of multiple sclerosis. Future Neurol: 2012; 7 6 679 700
39. Jain N., Bhatti M. T. Fingolimod-associated macular edema: incidence, detection, and management. Neurology: 2012; 78 9 672 680
40. Bermel R. A., Villoslada P. Retrograde trans-synaptic degeneration in MS: a missing link? Neurology: 2014; 82 24 2152 2153
41. Sorensen P. S., Bertolotto A., Edan G., et al. Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab. Mult Scler: 2012; 18 2 143 152
42. Prasad S., Galetta S. L. Eye movement abnormalities in multiple sclerosis. Neurol Clin: 2010; 28 3 641 655
43. Frohman T. C., Galetta S., Fox R., et al. Pearls & Oy-sters: the medial longitudinal fasciculus in ocular motor physiology. Neurology: 2008; 70 17 e57 e67
44. Wong A. M. Understanding skew deviation and a new clinical test to differentiate it from trochlear nerve palsy. J AAPOS: 2010; 14 1 61 67
45. Straube A., Bronstein A., Straumann D. Nystagmus and oscillopsia. In: Gilhus N. E., Barnes M. P., Brain M., eds. European Handbook of Neurological Management. Vol. 1. 2nd ed. Oxford Blackwell Publishing Ltd: 2011; 484 492